The PASI of 75% decline was not reached yet but is in decline vs time. If we had seen the 75% already the SP may have popped more. It was only in 4 people, 5 if you count from NASH trial. From other trials the placebo effect is less than 3% for psoriasis, so would be mostly drug effect. At the 75% reduction in psoriasis most are considered cleared. Need to see 8 of the 10 people get close or surpass the 75% to consider a P3 trial and will need funding for a P3. If it we can see a reverse in the upcoming NASH trial reporting in Sept. Than you will see a much bigger pop.
News 
Market Data 
Discover 
